These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The tumor suppressor hSNF5/INI1 modulates cell growth and actin cytoskeleton organization. Medjkane S; Novikov E; Versteege I; Delattre O Cancer Res; 2004 May; 64(10):3406-13. PubMed ID: 15150092 [TBL] [Abstract][Full Text] [Related]
4. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Caramel J; Medjkane S; Quignon F; Delattre O Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027 [TBL] [Abstract][Full Text] [Related]
5. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Oshiro Y; Izumi T; Taguchi T; Tsuneyoshi M Am J Surg Pathol; 2008 Aug; 32(8):1168-74. PubMed ID: 18580682 [TBL] [Abstract][Full Text] [Related]
6. A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesis. Craig E; Zhang ZK; Davies KP; Kalpana GV EMBO J; 2002 Jan; 21(1-2):31-42. PubMed ID: 11782423 [TBL] [Abstract][Full Text] [Related]
7. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Izumi T; Ohta S; Taguchi T; Suita S; Tsuneyoshi M J Cancer Res Clin Oncol; 2007 Nov; 133(11):817-24. PubMed ID: 17486366 [TBL] [Abstract][Full Text] [Related]
8. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Versteege I; Medjkane S; Rouillard D; Delattre O Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744 [TBL] [Abstract][Full Text] [Related]
9. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802 [TBL] [Abstract][Full Text] [Related]
10. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Cho YM; Choi J; Lee OJ; Lee HI; Han DJ; Ro JY Pathol Int; 2006 Nov; 56(11):702-6. PubMed ID: 17040295 [TBL] [Abstract][Full Text] [Related]
11. Establishment of a cell line from a malignant rhabdoid tumor of the liver lacking the function of two tumor suppressor genes, hSNF5/INI1 and p16. Kuroda H; Moritake H; Sawada K; Kuwahara Y; Imoto I; Inazawa J; Sugimoto T Cancer Genet Cytogenet; 2005 Apr; 158(2):172-9. PubMed ID: 15796965 [TBL] [Abstract][Full Text] [Related]
12. INI1 induces interferon signaling and spindle checkpoint in rhabdoid tumors. Morozov A; Lee SJ; Zhang ZK; Cimica V; Zagzag D; Kalpana GV Clin Cancer Res; 2007 Aug; 13(16):4721-30. PubMed ID: 17699849 [TBL] [Abstract][Full Text] [Related]
13. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Tsikitis M; Zhang Z; Edelman W; Zagzag D; Kalpana GV Proc Natl Acad Sci U S A; 2005 Aug; 102(34):12129-34. PubMed ID: 16099835 [TBL] [Abstract][Full Text] [Related]
14. The tumour suppressor hSNF5/INI1 controls the differentiation potential of malignant rhabdoid cells. Albanese P; Belin MF; Delattre O Eur J Cancer; 2006 Sep; 42(14):2326-34. PubMed ID: 16908131 [TBL] [Abstract][Full Text] [Related]
15. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280 [TBL] [Abstract][Full Text] [Related]
16. SNF5 reexpression in malignant rhabdoid tumors regulates transcription of target genes by recruitment of SWI/SNF complexes and RNAPII to the transcription start site of their promoters. Kuwahara Y; Wei D; Durand J; Weissman BE Mol Cancer Res; 2013 Mar; 11(3):251-60. PubMed ID: 23364536 [TBL] [Abstract][Full Text] [Related]
17. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Chai J; Charboneau AL; Betz BL; Weissman BE Cancer Res; 2005 Nov; 65(22):10192-8. PubMed ID: 16288006 [TBL] [Abstract][Full Text] [Related]
18. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner. Kato H; Honma R; Sanda T; Fujiwara T; Ito E; Yanagisawa Y; Imai J; Okamoto T; Watanabe S Biochem Biophys Res Commun; 2007 Sep; 361(3):580-5. PubMed ID: 17669367 [TBL] [Abstract][Full Text] [Related]
19. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression. Kohashi K; Nakatsura T; Kinoshita Y; Yamamoto H; Yamada Y; Tajiri T; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2013 Apr; 44(4):526-33. PubMed ID: 23084579 [TBL] [Abstract][Full Text] [Related]
20. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1. Caramel J; Quignon F; Delattre O Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]